Allspring Global Investments Holdings LLC lessened its holdings in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 60.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 13,906 shares of the company's stock after selling 21,541 shares during the quarter. Allspring Global Investments Holdings LLC owned about 0.07% of USANA Health Sciences worth $745,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in USANA Health Sciences by 60.6% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,376 shares of the company's stock worth $198,000 after acquiring an additional 1,274 shares during the last quarter. Teacher Retirement System of Texas bought a new position in shares of USANA Health Sciences during the 3rd quarter valued at approximately $297,000. Harbor Capital Advisors Inc. lifted its position in USANA Health Sciences by 32.7% in the fourth quarter. Harbor Capital Advisors Inc. now owns 6,282 shares of the company's stock worth $337,000 after buying an additional 1,547 shares during the last quarter. Illinois Municipal Retirement Fund bought a new stake in USANA Health Sciences in the third quarter worth $386,000. Finally, TD Asset Management Inc boosted its stake in USANA Health Sciences by 16.2% during the third quarter. TD Asset Management Inc now owns 8,600 shares of the company's stock worth $504,000 after buying an additional 1,200 shares during the period. Institutional investors own 54.25% of the company's stock.
USANA Health Sciences Trading Down 1.3 %
Shares of USNA traded down $0.58 during trading hours on Thursday, reaching $43.12. 111,811 shares of the company traded hands, compared to its average volume of 80,745. The stock's fifty day moving average price is $47.31 and its 200 day moving average price is $48.92. The firm has a market cap of $829.63 million, a price-to-earnings ratio of 13.01, a PEG ratio of 1.37 and a beta of 0.91. USANA Health Sciences, Inc. has a 12-month low of $42.59 and a 12-month high of $69.60.
USANA Health Sciences (NYSE:USNA - Get Free Report) last released its quarterly earnings data on Tuesday, February 6th. The company reported $0.87 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.52 by $0.35. USANA Health Sciences had a net margin of 6.93% and a return on equity of 13.49%. The firm had revenue of $221.08 million for the quarter, compared to the consensus estimate of $206.70 million. On average, research analysts forecast that USANA Health Sciences, Inc. will post 2.73 earnings per share for the current year.
Insider Activity at USANA Health Sciences
In related news, COO Walter Noot sold 5,240 shares of USANA Health Sciences stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $49.05, for a total transaction of $257,022.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other USANA Health Sciences news, COO Walter Noot sold 5,240 shares of USANA Health Sciences stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $49.05, for a total transaction of $257,022.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider David Mulham Mulham sold 4,311 shares of the company's stock in a transaction dated Thursday, February 29th. The stock was sold at an average price of $47.76, for a total value of $205,893.36. Following the completion of the sale, the insider now owns 7,825 shares in the company, valued at approximately $373,722. The disclosure for this sale can be found here. Insiders have sold a total of 24,807 shares of company stock valued at $1,200,791 in the last ninety days. Company insiders own 0.33% of the company's stock.
Analyst Ratings Changes
USNA has been the subject of several analyst reports. DA Davidson lowered their target price on shares of USANA Health Sciences from $53.00 to $48.00 and set a "neutral" rating for the company in a report on Thursday, February 22nd. StockNews.com raised shares of USANA Health Sciences from a "buy" rating to a "strong-buy" rating in a research note on Friday, January 12th.
Read Our Latest Analysis on USNA
About USANA Health Sciences
(
Free Report)
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Featured Stories
Before you consider USANA Health Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and USANA Health Sciences wasn't on the list.
While USANA Health Sciences currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
